Constellation Pharmaceuticals Provides Updated Preliminary Data from MANIFEST Clinical Trial with CPI-0610 in Oral and Poster Presentations at ASH


You May Also Like

Inspyr Therapeutics Appoints Claire Thom, Pharm.D. to Board of Directors

WESTLAKE VILLAGE, Calif., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a ...

Incysus Granted European Patent Covering its Drug Resistant Immunotherapy (DRI) Technology

HAMILTON, Bermuda, April 12, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused ...